Login / Signup

Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma.

Teresa PaínoLorena González-MéndezLaura San-SegundoLuis-Antonio CorcheteSusana Hernández-GarcíaAndrea Díaz-TejedorEsperanza M AlgarínPedro MogollónMontserrat Martín-SánchezNorma C GutiérrezMaría-Victoria MateosMercedes GarayoaEnrique María Ocio
Published in: Cancers (2020)
Altogether, our data support the clinical evaluation of the triple combination PIM-Pd for the treatment of patients with multiple myeloma.
Keyphrases
  • multiple myeloma
  • low dose
  • high dose
  • big data
  • protein protein
  • binding protein
  • combination therapy
  • small molecule
  • deep learning
  • artificial intelligence